1-20 of 46
Peng Liu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Generic Dasatinib As First-Line Treatment in Patients with Chronic Myeloid Leukemia in Chronic Phase: Final Analysis with 2-Year Follow-up

Jie Jin, Li Meng, Wenjuan Yu, Peng Liu, Xin Du, Jin Lou, Weiguang Wang
Journal: Blood
Blood (2021) 138 (Supplement 1): 3616.
DOI: https://doi.org/10.1182/blood-2021-150197
Published: 2021
Journal Articles

Efficacy and Safety of PD-1 Inhibitor Plus Rituximab in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Yan Qin, Xiaohui He, Sheng Yang, Peng Liu, Shengyu Zhou, Jianliang Yang, Lin Gui, Qiaofeng Zhong, Fengyi Zhao, Yuankai Shi, Hongmei Jing, Shiyue Zhang, Ruihan Guo, Yuankai Shi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2485.
DOI: https://doi.org/10.1182/blood-2021-152094
Published: 2021
Journal Articles

Spacing Constraints of Neighboring Zinc Finger Modules within GATA2

Mabel M. Jung, Koichi R. Katsumura, Peng Liu, Kirby D. Johnson, Joel P. Mackay, Lucy A. Godley, Emery H. Bresnick
Journal: Blood
Blood (2021) 138 (Supplement 1): 3306.
DOI: https://doi.org/10.1182/blood-2021-153023
Published: 2021
Journal Articles

Conditionally Pathogenic Genetic Variants of a Hematopoietic Disease-Suppressing Enhancer

Alexandra Soukup, Kirby D. Johnson, Peng Liu, Daniel R Matson, Emery H. Bresnick
Journal: Blood
Blood (2021) 138 (Supplement 1): 1078.
DOI: https://doi.org/10.1182/blood-2021-151008
Published: 2021
Journal Articles

Development and Validation of a Novel Prognostic Nomogram Model and a Web-Based Survival Rate Calculator for Diffuse Large B-Cell Lymphoma in the Rituximab Era

Qiaofeng Zhong, Haizhu Chen, Yan Qin, Xiaohui He, Sheng Yang, Shengyu Zhou, Peng Liu, Yuankai Shi, Hongmei Jing
Journal: Blood
Blood (2021) 138 (Supplement 1): 1450.
DOI: https://doi.org/10.1182/blood-2021-154210
Published: 2021
Journal Articles

Effect and Safety of Ixazomib Plus Dexamethasone (ID) in Patients with Waldenstrom's Macroglobulinemia (WM): Real-World Evidences from a Single Center in China

Jiadai Xu, Zheng Wei, MD, Jing Li, MD, Jingli Zhuang, Lili Ji, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5265.
DOI: https://doi.org/10.1182/blood-2019-128816
Published: 2019
Journal Articles

The Efficacy and Safety Profile of Ixazomib-Based Regimens in Patients with Relapsed/Refractory Multiple Myeloma in Routine Clinical Practice: Real World Data from a Multi-Center Study in China

Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Kaiyang Ding, Bingzong Li, MD PhD, Bing Chen, Zhengzheng Fu, Sili Wang, Wenhao Zhang, MD PhD, Xin Zhou, Luoming Hua, PhD, Wei Yang, Luo Jun, Liang Wang, Tianhong Xu, Yang Yang, Weida Wang, MD, Guolin Wu, Yun Huang, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5592.
DOI: https://doi.org/10.1182/blood-2019-130040
Published: 2019
Journal Articles

Breakthrough Hemolysis in Adult Patients with Paroxysmal Nocturnal Hemoglobinuria Treated with Ravulizumab: Results of a 52-Week Extension from Two Phase 3 Studies

Anita Hill, MD PhD, Caroline I. Piatek, Régis Peffault de Latour, MD PhD, Lily LL Wong, MD FRCPath, Richard A. Wells, MD DPhil, Robert A. Brodsky, MD, Jin Seok Kim, MD PhD, Junichi Nishimura, MD PhD, Philip Kuriakose, MD, Rodrigo Pavani, Peng Liu, Stephan Ortiz, RPh, PhD, Hubert Schrezenmeier, MD, Jong-Wook Lee, MD PhD, Austin Kulasekararaj, MDMBBS,MRCP,FRCPath
Journal: Blood
Blood (2019) 134 (Supplement_1): 952.
DOI: https://doi.org/10.1182/blood-2019-128929
Published: 2019
Journal Articles

Upfront Ixazomib Plus Dexamethasone Induce Promptly Hematological Response in Patients with Light-Chain Amyloidosis

Zheng Wei, MD, Yian Zhang, Jing Li, MD, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1908.
DOI: https://doi.org/10.1182/blood-2019-127023
Published: 2019
Journal Articles

GATA2 -Dependent Developmental and Regenerative Networks

Alexandra Soukup, PhD, Kirby D Johnson, PhD, Daniel J Conn, PhD, Evgenia Shishkova, PhD, Koichi Ricardo Katsumura, MD PhD, Peng Liu, PhD, Erik A. Ranheim, MD PhD, Katherine R. Calvo, MD PhD, Amy P. Hsu, Steven M. Holland, MD, Joshua J Coon, PhD, Sunduz Keles, PhD, Emery H Bresnick, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1182.
DOI: https://doi.org/10.1182/blood-2019-126875
Published: 2019
Journal Articles

Suppression of CXCL-1 Could Restore Necroptotic Pathway in Chronic Lymphocytic Leukemia

Zhao Xu, MD, Yifeng Sun, Zheng Wei, MD, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5466.
DOI: https://doi.org/10.1182/blood-2019-123748
Published: 2019
Journal Articles

Ixazomib-Based Frontline Therapy in Patients with Newly Diagnosed Multiple Myeloma in Real-Life Practice Showed Comparable Efficacy and Safety Profile with Those Reported in Randomized Clinical Trials: A Multi-Center Study in China

Jing Li, MD, Li Bao, Zhong-jun Xia, MD, Sili Wang, Xin Zhou, Kaiyang Ding, Wenhao Zhang, MD PhD, Wei Yang, Bingzong Li, MD PhD, Zhengzheng Fu, Bing Chen, Luoming Hua, PhD, Liang Wang, Luo Jun, Yang Yang, Tianhong Xu, Weida Wang, MD, Yun Huang, Guolin Wu, Peng Liu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3181.
DOI: https://doi.org/10.1182/blood-2019-128614
Published: 2019
Journal Articles

SOX17 Is Essential for Integration of Arterial and HOXA Programs in Hemogenic Endothelium

Ho Sun Jung, Gene I. Uenishi, PhD, Mi Ae Park, PhD, Peng Liu, PhD, Matthew Raymond, James Thomson, Irene Ong, Igor Slukvin, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2476.
DOI: https://doi.org/10.1182/blood-2019-130789
Published: 2019
Journal Articles

Loss-of-Function and Gain-of-Function Consequences of GATA2 Disease Mutations

Koichi Ricardo Katsumura, MD PhD, Peng Liu, PhD, Charu Mehta, MS, Kyle J Hewitt, PhD, Alexandra Soukup, PhD, Isabela J Fraga de Andrade, Bachelors in Biological Science, Erik A. Ranheim, MD PhD, Kirby D Johnson, PhD, Emery H Bresnick, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2519.
DOI: https://doi.org/10.1182/blood-2019-129447
Published: 2019
Journal Articles

Bone Marrow Tracer Uptake Pattern of PET/CT in Multiple Myeloma: Image Interpretation Criteria and Prognostic Value

Jing Li, MD, Hui Tan, PhD, Tianhong Xu, Hongcheng Shi, PhD, Peng Liu, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1900.
DOI: https://doi.org/10.1182/blood-2018-99-114370
Published: 2018
Journal Articles

Chidamide, a Novel Histone Deacetylase Inhibitor, Inhibits Multiple Myeloma Cells Proliferation through Succinate Dehydrogenase Subunit a

Yifeng Sun, Peng Liu, MD, Jing Li
Journal: Blood
Blood (2018) 132 (Supplement 1): 1965.
DOI: https://doi.org/10.1182/blood-2018-99-112747
Published: 2018
Journal Articles

Single-Nucleotide Human Disease Mutation Inactivates a Blood-Regenerative Enhancer

Alexandra Soukup, BS, PhD, Charu Mehta, MS, Peng Liu, PhD, Miao Cao, Inga Hofmann, MD, Yun Zhou, MS, Jing Zhang, PhD, Kyunghee Choi, PhD, Kirby D Johnson, PhD, Emery H Bresnick, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2564.
DOI: https://doi.org/10.1182/blood-2018-99-113008
Published: 2018
Journal Articles

A Prognostic Nomogram and Survival Analysis in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients

Shiyu Jiang, Yan Qin, Peng Liu, Jiangliang Yang, Sheng Yang, Xiaohui He, Shengyu Zhou, Lin Gui, Changgong Zhang, Liqiang Zhou, Ming-Zhe Han, Yan Sun, Yuankai Shi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2994.
DOI: https://doi.org/10.1182/blood-2018-99-116442
Published: 2018
Journal Articles

A Retrospective Analysis of Outcomes of Diffuse Large B Cell Lymphoma (DLBCL) in the Elder Patients in China

Peng Liu, Ying Han, Jianliang Yang, Xiaohui He, Changgong Zhang, Shengyu Zhou, Yan Qin, Liqiang Zhou, Song Yongwen, Ming-Zhe Han, MD, Yan Sun, Yuankai Shi, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5410.
DOI: https://doi.org/10.1182/blood-2018-99-116641
Published: 2018
Journal Articles

Identification of High Serum Apolipoprotein A1 As a Favorable Prognostic Indicator in Patients with Multiple Myeloma

Peng Liu, MD, Lifan Liang, Jing Li, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5589.
DOI: https://doi.org/10.1182/blood-2018-99-110919
Published: 2018